With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it's time to make the most of evolving process analytical technology to design robust and cost-effective control strategies and understand more about your biopharmaceutical products.
The likes of Bristol Myers Squibb, BMS, Vertex, Moderna, Sanofi and Novo Nordisk and more are uniting at the 2nd PAT and Real Time Quality Summit to revolutionize real-time quality strategies across a wide range of novel modality applications, and share advances in machine learning that are making real-time control and diversion a reality.
Time: 9:00 AM - 5:30 PM